Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1395
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7814.016
uM
86.84590
1000.00000
0.3508 -0.6755 0.3498 0.1708
0.7839
0.8623
HCC1395
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7815.016
uM
47.30110
203.97620
0.0252 -1.0000 0.7517 0.1275
0.9086
0.4370
BT-474
HER2amp
Luminal
TAPI-0
TACE/Collagenase
5905.096
uM
63.96990
112.68570
0.6808 -0.3704 0.9791 0.0316
0.8092
0.9091
HCC1395
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7816.016
uM
39.77890
185.42730
-0.0051 -1.0000 0.7137 0.1857
0.9465
1.1183
HCC1395
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7813.016
uM
38.11570
46.84880
-0.8358 -0.8400 4.7784 0.1276
0.9950
0.8531
AU565
HER2amp
Luminal
Glycyl-H-1152
ROCK2
10880.15
uM
9.07190
75.67630
0.2009 -1.0000 0.5179 0.1669
0.9797
1.5829
HCC1143
TNBC
Basal A
Glycyl-H-1152
ROCK2
12112.16
uM
13.0250
4.55930
0.3445 0.2984 0.8653 0.1600
0.9739
1.7073
HCC70
TNBC
Basal A
Ibandronate
FDPS
12400.143
uM
78.39170
75.29820
0.0680 0.0702 3.7592 0.2421
0.9652
1.3002
HCC3153
TNBC
Basal A
Ibandronate
FDPS
10937.143
uM
76.74170
86.08140
-0.1089 -0.1059 1.6725 0.2383
0.9923
1.3133
BT-20
TNBC
Basal A
Torkinib
15385.211
uM
0.00007
0.00943
-0.7410 -0.9904 0.2213 1.1960
0.990
0.7321
MDA-MB-453
TNBC
Luminal
Methylglyoxal
13647.184
uM
inf
inf
-0.8749 -0.8749 0.0000 0.3852
0.4269
1.2942
MCF12A
NM
Basal B
Glycyl-H-1152
ROCK2
10817.15
uM
inf
2.06940
0.5134 0.5168 4.9958 0.1013
0.9788
1.3689
MDA-MB-453
TNBC
Luminal
Mebendazole
12964.174
uM
0.21977
0.29241
-0.4032 -0.2943 1.6205 0.5795
0.9637
0.7885
MDA-MB-453
TNBC
Luminal
Mebendazole
13562.174
uM
0.10597
0.12962
-0.3553 -0.2507 2.0171 0.6156
0.9838
0.7219
MCF12A
NM
Basal B
Glycyl-H-1152
ROCK2
12365.169
uM
inf
2.76580
0.7240 0.7388 5.0000 0.0520
0.9488
2.1831
HCC1954
HER2amp
Basal A
CGC-11047
Polyamine analogue
9386.026
uM
1.40510
14.81740
-0.8956 -0.9802 0.4607 0.8841
0.9611
1.5583
MDA-MB-415
HR+
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
7897.016
uM
32.84980
48.58170
-0.9480 -1.0000 2.8076 0.2266
0.9871
0.7300
HCC1395
TNBC
Basal B
CGC-11047
Polyamine analogue
9254.124
uM
26.98710
1000.00000
0.1010 -0.7823 0.2607 0.2991
0.7092
0.8067
HCC1395
TNBC
Basal B
CGC-11047
Polyamine analogue
9258.026
uM
0.44087
35.50130
-1.0000 -1.0000 0.2503 0.8247
0.7494
0.5632
MDA-MB-175-VII
HR+
Luminal
Ibandronate
FDPS
12126.143
uM
83.13350
138.95970
-0.8487 -0.8720 1.9648 0.4595
0.9467
0.6729
HCC1395
TNBC
Basal B
CGC-11047
Polyamine analogue
7813.018
uM
67.35460
248.74160
-0.9987 -1.0000 0.8409 0.6221
0.8654
0.8420
HCC3153
TNBC
Basal A
Mebendazole
13583.174
uM
0.16580
0.26708
-0.6804 -0.5978 1.6495 0.6918
0.9714
0.3654
SUM225CWN
HER2amp
Basal A
Ribavirin
15403.211
uM
inf
inf
0.4799 0.4799 0.0000 0.2473
0.3950
0.7553
MDA-MB-453
TNBC
Luminal
Nelfinavir
12964.174
uM
5.03420
8.04630
-0.9964 -1.0000 2.3427 0.2872
0.9802
0.7885
MDA-MB-453
TNBC
Luminal
Nelfinavir
13562.174
uM
9.50690
8.91340
0.1303 0.1283 4.5978 0.0948
0.9810
0.7219